Cargando…

Detection of Gag C-terminal mutations among HIV-1 non-B subtypes in a subset of Cameroonian patients

Response to ritonavir-boosted-protease inhibitors (PI/r)-based regimen is associated with some Gag mutations among HIV-1 B-clade. There is limited data on Gag mutations and their covariation with mutations in protease among HIV-1 non-B-clades at PI/r-based treatment failure. Thus, we characterized G...

Descripción completa

Detalles Bibliográficos
Autores principales:	Teto, Georges, Nka, Alex Durand, Fokam, Joseph, Bouba, Yagai, Takou, Désiré, Fabeni, Lavinia, Carioti, Luca, Armenia, Daniele, Semengue, Ezéchiel Ngoufack Jagni, Dambaya, Béatrice, Sosso, Samuel Martin, Colizzi, Vittorio, Perno, Carlo-Federico, Ceccherini-Silberstein, Francesca, Santoro, Maria Mercedes, Ndjolo, Alexis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8791941/ https://www.ncbi.nlm.nih.gov/pubmed/35082353 http://dx.doi.org/10.1038/s41598-022-05375-9

Ejemplares similares

HIV-1 Gag gene mutations, treatment response and drug resistance to protease inhibitors: A systematic review and meta-analysis protocol
por: Nka, Alex Durand, et al.
Publicado: (2021)

HIV-1 integrase resistance associated mutations and the use of dolutegravir in Sub-Saharan Africa: A systematic review and meta-analysis
por: Ngoufack Jagni Semengue, Ezechiel, et al.
Publicado: (2022)

HIV-1 integrase resistance associated mutations and the use of dolutegravir in Sub-Saharan Africa: a systematic review and meta-analysis protocol
por: Semengue, Ezechiel Ngoufack Jagni, et al.
Publicado: (2020)

Global burden of SARS-CoV-2 infection, hospitalization and case fatality rate among COVID-19 vaccinated individuals and its associated factors: A systematic review and meta-analysis protocol
por: Nka, Alex Durand, et al.
Publicado: (2022)

Laboratory Based Surveillance of HIV-1 Acquired Drug Resistance in Cameroon: Implications for Use of Tenofovir-Lamivudine-Dolutegravir (TLD) as Second- or Third-Line Regimens
por: Fokam, Joseph, et al.
Publicado: (2023)

Characterisation of HIV-1 reservoirs in paediatric populations: protocol for a systematic review and meta-analysis
por: Ka’e, Aude Christelle, et al.
Publicado: (2023)

Pre-Treatment HIV Drug Resistance and Genetic Diversity in Cameroon: Implications for First-Line Regimens
por: Fokam, Joseph, et al.
Publicado: (2023)

The mother-to-child transmission of HIV-1 and profile of viral reservoirs in pediatric population: A systematic review with meta-analysis of the Cameroonian studies
por: Ka’e, Aude Christelle, et al.
Publicado: (2023)

High genotypic diversity of human papillomavirus among women in Cameroon: implications for vaccine effectiveness
por: Tchouaket, Michel Carlos Tommo, et al.
Publicado: (2022)

Human papillomavirus positivity and cervical lesions in relation to HIV infection: a comparative assessment in the Cameroonian female population
por: SOSSO, SAMUEL MARTIN, et al.
Publicado: (2023)

Variability of High-Risk Human Papillomavirus and Associated Factors among Women in Sub-Saharan Africa: A Systematic Review and Meta-Analysis
por: Tchouaket, Michel Carlos Tommo, et al.
Publicado: (2023)

Dolutegravir-Based Regimen Ensures High Virological Success despite Prior Exposure to Efavirenz-Based First-LINE ART in Cameroon: An Evidence of a Successful Transition Model
por: Semengue, Ezechiel Ngoufack Jagni, et al.
Publicado: (2022)

HIV-1 genotypic profiling ensures effective response to third-line antiretroviral therapy in Cameroon
por: Mbouyap, Pretty Rosereine, et al.
Publicado: (2023)

COVID-19 preventive social-behavioural practices and exposure to SARS-CoV-2 among residents in the city of Yaounde: Lessons from the early phase of the pandemic in Cameroon
por: Fokam, Joseph, et al.
Publicado: (2023)

Next-generation sequencing provides an added value in determining drug resistance and viral tropism in Cameroonian HIV-1 vertically infected children
por: Fokam, Joseph, et al.
Publicado: (2018)

Thrombocytopenia according to antiretroviral drug combinations, viremia and CD4 lymphocytes among HIV-infected patients in Cameroon: a snapshot from the City of Yaoundé
por: Nka, Alex Durand, et al.
Publicado: (2019)

Genotypic resistance testing improves antiretroviral treatment outcomes in a cohort of adolescents in Cameroon: Implications in the dolutegravir-era
por: PABO, WILLY LE ROI TOGNA, et al.
Publicado: (2023)

Evaluation of Circulating and Archived HIV-1 Integrase Drug-Resistance Variants among Patients on Third-Line ART in Cameroon: Implications for Dolutegravir-Containing Regimens in Resource-Limited Settings
por: Fokam, Joseph, et al.
Publicado: (2022)

Epidemiological, virological and clinical features of SARS-CoV-2 among individuals during the first wave in Cameroon: Baseline analysis for the EDCTP PERFECT-Study RIA2020EF-3000
por: Fokam, Joseph, et al.
Publicado: (2022)

HIV-1 drug resistance testing is essential for heavily-treated patients switching from first- to second-line regimens in resource-limited settings: evidence from routine clinical practice in Cameroon
por: Takou, Desire, et al.
Publicado: (2019)

Human immunodeficiency virus is a driven factor of human papilloma virus among women: evidence from a cross-sectional analysis in Yaoundé, Cameroon
por: Sosso, Samuel Martin, et al.
Publicado: (2020)

Determinants of periodontitis according to the immunological and virological profiles of HIV-infected patients in Yaoundé, Cameroon
por: Fokam, Joseph, et al.
Publicado: (2020)

Characterization of oral candidiasis according to antiretroviral treatment status, immunological and virological profiles among HIV infected patients in two health facilities in Yaoundé-Cameroon: a cross-sectional and analytical study
por: Fokam, Joseph, et al.
Publicado: (2023)

High concordance in SARSCoV-2 detection between automated (Abbott m2000) and manual (DaAn gene) RT-PCR systems: The EDCTP PERFECT-Study in Cameroon
por: Fainguem, Nadine Nguendjoung, et al.
Publicado: (2022)

Pre-treatment drug resistance and HIV-1 genetic diversity in the rural and urban settings of Northwest-Cameroon
por: Fokam, Joseph, et al.
Publicado: (2020)

HIV-1 subtype diversity and immuno-virological outcomes among adolescents failing antiretroviral therapy in Cameroon: A cohort study
por: Togna Pabo, Willy Le roi, et al.
Publicado: (2023)

First case of Dolutegravir and Darunavir/r multi drug-resistant HIV-1 in Cameroon following exposure to Raltegravir: lessons and implications in the era of transition to Dolutegravir-based regimens
por: Fokam, Joseph, et al.
Publicado: (2020)

Correlation between the immuno-virological response and the nutritional profile of treatment-experienced HIV-infected patients in the East region of Cameroon
por: Abba, Aissatou, et al.
Publicado: (2021)

Viral suppression in adults, adolescents and children receiving antiretroviral therapy in Cameroon: adolescents at high risk of virological failure in the era of “test and treat”
por: Fokam, Joseph, et al.
Publicado: (2019)

TRIM5α 136Q, CCR5 Promoter 59029G And CCR264I Alleles Impact The Progression Of HIV In Children And Adolescents
por: Dambaya, Béatrice, et al.
Publicado: (2019)

Diagnostic performance of molecular and serological tests of SARS-CoV-2 on well-characterised specimens from COVID-19 individuals: The EDCTP "PERFECT-study" protocol (RIA2020EF-3000)
por: Fokam, Joseph, et al.
Publicado: (2022)

Challenges faced by the HIV testing system in low- and middle-income countries
por: Kamgaing, Rachel S., et al.
Publicado: (2023)

The 2nd International Conference on Public Health in Africa 12-15 December 2022, Kigali Rwanda
por: Colizzi, Vittorio, et al.
Publicado: (2023)

Pre-existing immunity to SARS-CoV-2 before the COVID-19 pandemic era in Cameroon: A comparative analysis according to HIV-status
por: Aissatou, Abba, et al.
Publicado: (2023)

Evaluation of treatment response, drug resistance and HIV-1 variability among adolescents on first- and second-line antiretroviral therapy: a study protocol for a prospective observational study in the centre region of Cameroon (EDCTP READY-study)
por: Fokam, Joseph, et al.
Publicado: (2019)

Viral suppression in the era of transition to dolutegravir-based therapy in Cameroon: Children at high risk of virological failure due to the lowly transition in pediatrics
por: Fokam, Joseph, et al.
Publicado: (2023)

Inflammatory profile of vertically HIV-1 infected adolescents receiving ART in Cameroon: a contribution toward optimal pediatric HIV control strategies
por: Ka’e, Aude Christelle, et al.
Publicado: (2023)

Differential expression of Fas receptors (CD95) and Fas ligands (CD95L) in HIV infected and exposed uninfected children in Cameroon versus unexposed children
por: Dambaya, Béatrice, et al.
Publicado: (2019)

Programme quality indicators of HIV drug resistance among adolescents in urban versus rural settings of the centre region of Cameroon
por: Fokam, Joseph, et al.
Publicado: (2020)

Prevalence of HIV, HBV and chlamydia infections in Cameroonian University context: case of the University of Dschang, in the Western region
por: Sobze, Martin Sanou, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_qjnbqecff7mjpfvj6efasiprb6